San Francisco, California
London, United Kingdom
‘Developing the Treatments of Tomorrow’
Speeding up drug development for Parkinson’s through Virtual Biotech
The treatments we currently have for Parkinson’s work by masking its symptoms. But they cannot stop the loss of precious brain cells. We need better treatments that slow, stop or even reverse Parkinson’s.
In this lecture, we’ll hear about two exciting projects that aim to tackle the underlying causes of Parkinson’s by changing the way the brain cells work.
In the first part for this lecture, we’ll hear from Dr Richard Mead, University of Sheffield. He will introduce his new Virtual biotech project, and explain how working in this new virtual way can accelerate drug discovery and get new treatments to those who need them faster.
We’ll then hear from Dr Oscar Cordero Llana, University of Bristol, whose project, investigating a combined therapy for Parkinson’s, builds on promising research currently in clinical trials.
Join us to hear more about their groundbreaking studies and put your questions to the experts.
Save This Event
When & Where
We're the Parkinson's support and research charity. For more than 40 years we've been working to find a cure and improve life for everyone affected by Parkinson's.